A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression

Sponsor
National Center for Telehealth and Technology (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01599585
Collaborator
VA Office of Research and Development (U.S. Fed)
121
2
2
53
60.5
1.1

Study Details

Study Description

Brief Summary

This study will evaluate the effectiveness of a web-based behavioral activation(BA) treatment for depression by comparing it to in-person BA treatment in Soldiers and Veterans with Major and Minor Depressive Disorder. We will test the hypothesis that 8 sessions of in-home BA delivered via a webcam will be as safe and effective in reducing symptoms of hopelessness and depression as in-person BA treatment for depression.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Behavioral Activation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
121 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Trial of In-Home Tele-behavioral Health Care Utilizing Behavioral Activation for Depression
Study Start Date :
May 1, 2012
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Oct 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: In Home

Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology.

Behavioral: Behavioral Activation
Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
Other Names:
  • BA
  • Active Comparator: In-Person

    Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology.

    Behavioral: Behavioral Activation
    Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Other Names:
  • BA
  • Outcome Measures

    Primary Outcome Measures

    1. Beck Hopelessness Scale (BHS) [Post treatment - Week 8]

      The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.

    Secondary Outcome Measures

    1. Adverse Events [Treatment Session Week 1]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    2. Beck Depression Inventory -II (BDI-II) [Baseline]

      The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome.

    3. Adverse Events [Treatment Session Week 2]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    4. Adverse Events [Treatment Session Week 3]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    5. Adverse Events [Treatment Session Week 4]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    6. Adverse Events [Treatment Session Week 5]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    7. Adverse Events [Treatment Session Week 6]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    8. Adverse Events [Treatment Session Week 7]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    9. Adverse Events [Treatment Session Week 8]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    10. Adverse Events [3 month follow up]

      Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.

    11. Beck Depression Inventory -II (BDI-II) [Midpoint- Week 4]

      The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome

    12. Beck Depression Inventory -II (BDI-II) [Post Treatment- Week 8]

      The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome.

    13. Beck Depression Inventory -II (BDI-II) [3 month follow up]

      The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome.

    14. Beck Hopelessness Scale (BHS) [Baseline]

      The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.

    15. Beck Hopelessness Scale (BHS) [Midpoint- Week 4]

      The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.

    16. Beck Hopelessness Scale (BHS) [3 month follow up]

      The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Current Major Depressive or Minor Depressive Disorder

    • High-speed internet/network access at home (384kbs minimum)

    • Informed consent

    • Fluent in the English language

    Exclusion Criteria:
    • Currently undergoing psychotherapy for depression

    • less than 18 or greater than 65 year of age

    • Active psychotic symptoms/disorders as determined by the SCID for DSM-IV

    • Dysthymic Disorder

    • Current suicidal ideation with intent or recent (within six months) history of a suicide attempt

    • History of Organic Mental Disorder

    • Current substance dependence as determined by the SCID (lifetime substance dependence or substance abuse will not be excluded)

    • History of violence or poor impulse control causing potential risk to staff or others

    • Significant ongoing stressors that require urgent crisis intervention

    • Having a living arrangement that will not permit the use of a private space to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Portland VA Medical Center Portland Oregon United States 97207
    2 National Center for Telehealth and Technology Tacoma Washington United States 98431

    Sponsors and Collaborators

    • National Center for Telehealth and Technology
    • VA Office of Research and Development

    Investigators

    • Principal Investigator: Gregory A Gahm, PhD, National Center for Telehealth and Technology
    • Principal Investigator: David D Luxton, PhD, National Center for Telehealth & Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    National Center for Telehealth and Technology
    ClinicalTrials.gov Identifier:
    NCT01599585
    Other Study ID Numbers:
    • W81XWH-11-2-0118
    • W81XWH-11-2-0118
    First Posted:
    May 16, 2012
    Last Update Posted:
    Jun 16, 2017
    Last Verified:
    Mar 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by National Center for Telehealth and Technology
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Period Title: Overall Study
    STARTED 62 59
    COMPLETED 40 42
    NOT COMPLETED 22 17

    Baseline Characteristics

    Arm/Group Title In Home In-Person Total
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Total of all reporting groups
    Overall Participants 62 59 121
    Age (Count of Participants)
    <=18 years
    0
    0%
    0
    0%
    0
    0%
    Between 18 and 65 years
    62
    100%
    59
    100%
    121
    100%
    >=65 years
    0
    0%
    0
    0%
    0
    0%
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    34.8
    (12.4)
    35.6
    (11.8)
    35.1
    (12.1)
    Sex: Female, Male (Count of Participants)
    Female
    10
    16.1%
    12
    20.3%
    22
    18.2%
    Male
    52
    83.9%
    47
    79.7%
    99
    81.8%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    3
    4.8%
    7
    11.9%
    10
    8.3%
    Not Hispanic or Latino
    56
    90.3%
    52
    88.1%
    108
    89.3%
    Unknown or Not Reported
    3
    4.8%
    0
    0%
    3
    2.5%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    1
    1.6%
    0
    0%
    1
    0.8%
    Asian
    3
    4.8%
    1
    1.7%
    4
    3.3%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    0
    0%
    0
    0%
    Black or African American
    8
    12.9%
    10
    16.9%
    18
    14.9%
    White
    44
    71%
    41
    69.5%
    85
    70.2%
    More than one race
    0
    0%
    0
    0%
    0
    0%
    Unknown or Not Reported
    6
    9.7%
    7
    11.9%
    13
    10.7%
    Region of Enrollment (participants) [Number]
    United States
    62
    100%
    59
    100%
    121
    100%

    Outcome Measures

    1. Primary Outcome
    Title Beck Hopelessness Scale (BHS)
    Description The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.
    Time Frame Post treatment - Week 8

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 45 42
    Mean (Standard Deviation) [units on a scale]
    4.888889
    (4.642796)
    4.428571
    (4.939353)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection In Home, In-Person
    Comments
    Type of Statistical Test Non-Inferiority or Equivalence
    Comments One tailed test at .05a = .05 margin was set at standardized difference of .50
    Statistical Test of Hypothesis p-Value
    Comments
    Method
    Comments
    Method of Estimation Estimation Parameter Regression, Beta
    Estimated Value 0.40
    Confidence Interval (2-Sided) 90%
    .12 to .68
    Parameter Dispersion Type:
    Value:
    Estimation Comments
    2. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 1

    Outcome Measure Data

    Analysis Population Description
    AE data reported in adverse events section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 62 59
    Number [participants]
    0
    0%
    0
    0%
    3. Secondary Outcome
    Title Beck Depression Inventory -II (BDI-II)
    Description The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome.
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 62 59
    Mean (Standard Deviation) [units on a scale]
    27.59678
    (10.44652)
    29.71186
    (11.33054)
    4. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 2

    Outcome Measure Data

    Analysis Population Description
    adverse event data reported in adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 62 59
    Number [participants]
    0
    0%
    0
    0%
    5. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 3

    Outcome Measure Data

    Analysis Population Description
    adverse event data reported in adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 62 59
    Number [participants]
    62
    100%
    59
    100%
    6. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 4

    Outcome Measure Data

    Analysis Population Description
    Adverse Event data recorded in Adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 48 44
    Number [participants]
    0
    0%
    0
    0%
    7. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 5

    Outcome Measure Data

    Analysis Population Description
    adverse events are reported in adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 48 44
    Number [participants]
    0
    0%
    0
    0%
    8. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 6

    Outcome Measure Data

    Analysis Population Description
    adverse events are reported in the adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 48 44
    Number [participants]
    0
    0%
    0
    0%
    9. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 7

    Outcome Measure Data

    Analysis Population Description
    adverse events are reported in adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 45 42
    Number [participants]
    0
    0%
    0
    0%
    10. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame Treatment Session Week 8

    Outcome Measure Data

    Analysis Population Description
    Adverse event data recorded in adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 45 42
    Number [participants]
    0
    0%
    0
    0%
    11. Secondary Outcome
    Title Adverse Events
    Description Safety data will be collected on adverse events, psychiatric hospitalizations, suicides and non-fatal suicide-related behaviors, number of times the treatment collateral was utilized during treatment, treatment adherence, participant drop-out rate, and frequency of requests for patient or therapist technical support. Safety related data will be recorded after each treatment session on the Treatment Session Checklist.
    Time Frame 3 month follow up

    Outcome Measure Data

    Analysis Population Description
    Adverse event data is recorded in adverse event section
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 42 36
    Number [participants]
    6
    9.7%
    2
    3.4%
    12. Secondary Outcome
    Title Beck Depression Inventory -II (BDI-II)
    Description The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome
    Time Frame Midpoint- Week 4

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 47 44
    Mean (Standard Deviation) [units on a scale]
    19.40425
    (11.77444)
    20.20455
    (13.09106)
    13. Secondary Outcome
    Title Beck Depression Inventory -II (BDI-II)
    Description The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome.
    Time Frame Post Treatment- Week 8

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 62 59
    Mean (Standard Deviation) [units on a scale]
    13.82222
    (12.01947)
    11.7381
    (12.07509)
    Statistical Analysis 1
    Statistical Analysis Overview Comparison Group Selection In Home, In-Person
    Comments
    Type of Statistical Test Non-Inferiority or Equivalence
    Comments One tailed test at .05a = .05 margin was set at standardized difference of .50
    Statistical Test of Hypothesis p-Value
    Comments
    Method
    Comments
    Method of Estimation Estimation Parameter Regression, Beta
    Estimated Value .47
    Confidence Interval (2-Sided) 90%
    .16 to .78
    Parameter Dispersion Type:
    Value:
    Estimation Comments
    14. Secondary Outcome
    Title Beck Depression Inventory -II (BDI-II)
    Description The BDI-II is the most commonly used self-report measure of clinical depression severity. It consists of 21 items that are rated on a 4-point scale which yield a range of scores from 0 - 63. The BDI-II has sound psychometric properties. The higher the score the worse the outcome.
    Time Frame 3 month follow up

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 42 36
    Mean (Standard Deviation) [units on a scale]
    14.7619
    (12.88752)
    15
    (12.61065)
    15. Secondary Outcome
    Title Beck Hopelessness Scale (BHS)
    Description The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.
    Time Frame Baseline

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 62 59
    Mean (Standard Deviation) [units on a scale]
    9
    (5.118273)
    10.37288
    (6.133285)
    16. Secondary Outcome
    Title Beck Hopelessness Scale (BHS)
    Description The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.
    Time Frame Midpoint- Week 4

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 48 44
    Mean (Standard Deviation) [units on a scale]
    7.041667
    (5.63786)
    7.954545
    (6.261564)
    17. Secondary Outcome
    Title Beck Hopelessness Scale (BHS)
    Description The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.
    Time Frame 3 month follow up

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    Measure Participants 42 36
    Mean (Standard Deviation) [units on a scale]
    5.214286
    (5.101582)
    5.527778
    (5.973686)

    Adverse Events

    Time Frame Adverse events were collected from time of consent to final outcome assessment
    Adverse Event Reporting Description
    Arm/Group Title In Home In-Person
    Arm/Group Description Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week). The sessions will be conducted in their homes using an Army approved secure web-based video conferencing system. BA has been successfully delivered in this time frame, and it has been delivered via in-home video conferencing technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies. Participants in this condition will receive 8 sessions of BA treatment over the course of approximately 8 weeks (one session per week with allowance for rescheduled sessions). The sessions will be conducted in a clinic setting at The National Center for Telehealth & Technology. Behavioral Activation: Behavioral activation(BA)will be delivered in 8 weekly sessions via webcam for the in-home arm or face to face in the in-person arm. Behavioral activation attempts to help depressed individuals reengage in their lives through focused activation strategies.
    All Cause Mortality
    In Home In-Person
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    In Home In-Person
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 3/62 (4.8%) 1/59 (1.7%)
    Cardiac disorders
    Severe chest pain 0/62 (0%) 0 1/59 (1.7%) 1
    Immune system disorders
    hospitalization for high fever and chills 1/62 (1.6%) 1 0/59 (0%) 0
    Psychiatric disorders
    exacerbation of baseline suicidality 1/62 (1.6%) 1 0/59 (0%) 0
    Respiratory, thoracic and mediastinal disorders
    exacerbation of asthma symptoms requiring hospitalization 1/62 (1.6%) 1 0/59 (0%) 0
    Other (Not Including Serious) Adverse Events
    In Home In-Person
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 3/62 (4.8%) 1/59 (1.7%)
    General disorders
    broken nose 1/62 (1.6%) 1 0/59 (0%) 0
    syncopial episode 1/62 (1.6%) 1 0/59 (0%) 0
    Musculoskeletal and connective tissue disorders
    tore tendons in foot 1/62 (1.6%) 1 0/59 (0%) 0
    broken finger 0/62 (0%) 0 1/59 (1.7%) 1

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Larry D. Pruitt, PhD
    Organization National Center for Telehealth and Technology
    Phone 253-968-2946
    Email larry.d.pruitt21.civ@mail.mil
    Responsible Party:
    National Center for Telehealth and Technology
    ClinicalTrials.gov Identifier:
    NCT01599585
    Other Study ID Numbers:
    • W81XWH-11-2-0118
    • W81XWH-11-2-0118
    First Posted:
    May 16, 2012
    Last Update Posted:
    Jun 16, 2017
    Last Verified:
    Mar 1, 2017